Aberrant, persistent inclusion into lipid rafts limits the tumorigenic function of membrane type-1 matrix metalloproteinase in malignant cells

被引:66
作者
Rozanov, DV [1 ]
Deryugina, EI [1 ]
Monosov, EZ [1 ]
Marchenko, ND [1 ]
Strongin, AY [1 ]
机构
[1] Burnham Inst, Ctr Canc Res, La Jolla, CA 92037 USA
关键词
invasion; migration; extracellular matrix; breast carcinoma; glioblastoma; xenografts; lipid rafts; caveolin;
D O I
10.1016/j.yexcr.2003.10.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Membrane type-1 matrix metalloprotemase (MT1-MMP) is a key enzyme in cell locomotion and tissue remodeling. Trafficking to the plasma membrane and internalization into the transient storage compartment both regulate the cell surface presentation of MT1-MMP. Our data indicate that mutant MT1-MMP lacking the cytoplasmic tail is recruited to the caveolae-enriched lipid raft membrane microdomains in breast carcinoma MCF7 cells. In contrast, the wild-type protease is not permanently associated with lipid rafts. Trafficking to lipid rafts correlated with poor internalization and the persistent presentation of MT1-MMP at the cell surface. The tail mutant efficiently functioned in inducing the activation of the latent proMMP-2 zymogen, matrix remodeling, and contraction of three-dimensional collagen lattices. Recruitment of the tail mutant to lipid raft antagonized, however, the cleavage of the plasma membrane-associated E-cadherin. These events limited the contribution of the tail mutant to cell locomotion and malignant growth. It is conceivable that the tail peptide sequence plays a crucial role in the translocations of MT1-MMP across the cell and contributes to coordinated cellular functions. It is tempting to hypothesize that the mechanisms involved in trafficking of MT1-MMP to caveolin-enriched lipid rafts may be targeted in a clinically advantageous manner. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:81 / 95
页数:15
相关论文
共 65 条
[1]   The caveolae membrane system [J].
Anderson, RGW .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :199-225
[2]   Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains [J].
Annabi, B ;
Lachambre, MP ;
Bousquet-Gagnon, N ;
Pagé, M ;
Gingras, D ;
Béliveau, R .
BIOCHEMICAL JOURNAL, 2001, 353 :547-553
[3]   Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells [J].
Bassi, DE ;
De Cicco, RL ;
Mahloogi, H ;
Zucker, S ;
Thomas, G ;
Klein-Szanto, AJP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10326-10331
[4]   Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion [J].
Belkin, AM ;
Akimov, SS ;
Zaritskaya, LS ;
Ratnikov, BI ;
Deryugina, EI ;
Strongin, AY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :18415-18422
[5]  
BORDIER C, 1981, J BIOL CHEM, V256, P1604
[6]   TRITON X-114 PHASE FRACTIONATION OF MEMBRANE-PROTEINS OF THE CYANOBACTERIUM ANACYSTIS-NIDULANS R2 [J].
BRICKER, TM ;
SHERMAN, LA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1984, 235 (01) :204-211
[7]   MT1-MMP initiates activation of pro-MMP-2 and integrin αvβ3 promotes maturation of MMP-2 in breast carcinoma cells [J].
Deryugina, EI ;
Ratnikov, B ;
Monosov, E ;
Postnova, TI ;
DiScipio, R ;
Smith, JW ;
Strongin, AY .
EXPERIMENTAL CELL RESEARCH, 2001, 263 (02) :209-223
[8]   Prinomastat, a hydroxamate inhibitor of matrix metalloproteinases, has a complex effect on migration of breast carcinoma cells [J].
Deryugina, EI ;
Ratnikov, BI ;
Strongin, AY .
INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (05) :533-541
[9]  
Deryugina EI, 1997, J CELL SCI, V110, P2473
[10]  
Deryugina EI, 2002, CANCER RES, V62, P580